Core Management for all Patients with knee osteoarthritis
First-line (Mild pain): Topical NSAIDs Diclofenac 1% gel: 2–4 g applied QID directly to knee (max 16 g/day/joint). |
If Moderate/Severe or persistent Pain: Short-Term Oral NSAIDs Diclofenac 50 mg BID or TID (preferred first-line oral NSAID for knee OA when topical therapy is insufficient, due to strong efficacy evidence). Naproxen 250–500 mg BID (effective alternative with a relatively safer cardiovascular profile for longer-term use). Meloxicam 7.5–15 mg once daily (when simplified once-daily dosing is desired or when GI tolerability is a concern, has similar overall efficacy to other NSAIDs). |
Before prescribing NSAIDs:
NOTE: Paracetamol is no longer first-line for osteoarthritis due to limited analgesic efficacy, even at full regular dosing. It may be considered as adjunctive therapy or for patients who cannot tolerate NSAIDs, but its benefit remains modest and inferior to NSAIDs
Indications for Referral to Orthopedic clinic:
Persistent moderate-severe symptoms despite 6 months of PHC management
Confirmed advanced knee osteoarthritis (Level 3-4)
Symptoms affecting quality of life and/or sleep.
Significant impact on daily activity and functional capacity.
Patient is medically fit and accepting surgical treatment.
Author: Dr. Fahad Saad Almutairi,
Reviewer: Dr. Bader Thuwaini Alanazi